El CubeSat Juventas, una diminuta nave espacial del tamaño de una caja de zapatos, entregada a la Agencia Espacial Europea (ESA) hace varios días para la misión Hera, promete dar un salto de gigante en las investigaciones sobre asteroides. Una vez liberada desde la sond …
La futura aventura del CubeSat Juventas en los asteroides Didymos y Dimorphos Read More »
Aunque la impresión 3D se ha hecho muy popular, muchos de los materiales plásticos que utilizan estas impresoras para crear objetos no pueden reciclarse fácilmente. Aunque están surgiendo nuevos materiales sostenibles para su uso en impresión 3D, siguen siendo dif& …
Impresora 3D que deduce por sí sola cómo imprimir usando un material desconocido Read More »
Una teoría popular sobre el cerebro sostiene que su función principal es predecir lo que sucederá a continuación, de manera que tiende a prepararse para lo que es más probable que ocurra. La mayoría de las investigaciones sobre este tema se han centrado &uac …
PureTech Health plc announced that the U.S. Food and Drug Administration has granted Fast Track designation for LYT-200 in combination with anti-PD1 therapy for the treatment of recurrent/metastatic head and neck squamous cell carcinomas.
PureTech Receives FDA Fast Track Designation for LYT-200 in Head and Neck Cancers Read More »
Oncolytics Biotech® Inc., a leading clinical-stage company specializing in immunotherapeutics for oncology, is pleased to announce the submission of a Type C meeting request to the FDA.
ProPharma, the leading global provider of regulatory, clinical, and compliance services for the life sciences industry and a portfolio company of Odyssey Investment Partners is pleased to announce that it has welcomed Kirk Wroblewski as its new Chief Information Officer and Andrew Shaw as General Counsel.
ProPharma Announces Changes to Its Executive Leadership Team Read More »
West Pharmaceutical Services, Inc. announced that it will release first-quarter financial results before the market opens on Thursday, April 25, 2024, and will follow with a conference call to discuss the results and business expectations at 9:00 a.m. Eastern Time.
XVIVO Perfusion AB, at the 2024 International Society of Heart and Lung Transplantation meeting in Prague, Czech Republic, the results from XVIVO’s clinical trial, NIHP2019, in heart transplantation were presented.
Biovica International The Nomination Committee prior to the 2024 Annual General Meeting will consist of three members, who shall represent the two shareholders with the highest number of shares who accept the assignment to be part of the Nomination Committee as of December 31, 2023, and the Chairman of the Board.
Nomination Committee for Biovica International AB for the 2024 Annual General Meeting Read More »
Existen síndromes que desafían la comprensión y conmocionan tanto a pacientes como a profesionales de la salud. Estos trastornos, a menudo raros pero impactantes, presentan desafíos únicos tanto en diagnóstico como en tratamiento. 1. Síndrome …
Los síndromes que conmocionan el mundo científico Read More »
